T1	Outcomes 0 19	Efficacy and safety
T2	Outcomes 323 342	efficacy and safety
T3	Outcomes 755 780	relieved symptoms of CIU.
T4	Outcomes 811 882	severity of pruritus (visual analogue score (VAS) assessed by patients)
T5	Outcomes 1294 1315	episodes of urticaria
T6	Outcomes 1471 1481	Angioedema
T7	Outcomes 1642 1662	Overall tolerability
T8	Outcomes 1744 1777	effects on cardiac repolarisation
T9	Outcomes 1873 1901	effective and well tolerated
T10	Outcomes 2042 2061	urticarial symptoms
